Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative...

| |
Fannin, R.D., Russo, M., O'Connell, T.M., Gerrish, K., Winnike, J.H., Macdonald, J., Newton, J., Malik, S., Sieber, S.O., Parker, J., Shah, R., Zhou, T., Watkins, P.B., & Paules, R.S. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology, 2010; 51(1):277-236. doi:10.1002/hep.23330.

Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia

| |
Martin, J.N., Bair, T.B., Bode, N., Dauer, W.T., & Gonzalez-Alegre, P. Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia. Cellular Neuroscience, 2009. doi:10.1016/j.neuroscience.2009.07.068.

Pharmacogenomics of metabolic effects of rosiglitazone

| |
Šeda, O., Šedová, L., Oliyarnyk, O., Kazdová, L., Køenová, Corbeil, G., Hamet, P., Tremblay, J., & Køen. Pharmacogenomics of metabolic effects of rosiglitazone. Pharmacogenomics, 2009; 9(2):141-155. doi:10.2217/14622416.9.2.141.

Normalization strategies for metabonomic analysis of urine samples

| |
Warrack, B.M., Hnatyshyn, S., Ott, K-H., Reily, M.D., Sanders, M., Zhang, H., & Drexler, D.M. Normalization strategies for metabonomic analysis of urine samples. Journal of Chromatography, 2009; 877(5-6):547-552.